Serum soluble mesothelin related proteins level is predictive of survival among pleural malignant mesothelioma patients

被引：0
|
作者：
Puntoni, R.
Mutti, L.
Foddis, R.
Cristaudo, A.
Neri, M.
Paganuzzi, M.
Filiberti, R.
机构：
[1] Natl Canc Res Inst, Genoa, Italy
[2] Local Hlth Unit, Dept Med, Vercelli, Italy
[3] Univ Pisa, Pisa, Italy
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [41] Evaluation of soluble mesothelin-related peptide as a marker additional to cytology for diagnosing malignant pleural mesothelioma effusions.
    Vigani, Antonella
    Ferro, Paola
    Canessa, Pier Aldo
    Battolla, Enrico
    Dessanti, Paolo
    Manta, Carmen
    Aschele, Carlo
    Franceschini, Maria Cristiana
    Fontana, Vincenzo
    Fedeli, Franco
    Roncella, Silvio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Early detection of malignant pleural mesothelioma through measurement of soluble mesothelin-related protein and positron emission tomography
    O'Lone, Emma L.
    Park, Eun-Kee
    Sandrini, Alessandra
    Fogarty, Gerald B.
    Yates, Deborah H.
    MEDICAL JOURNAL OF AUSTRALIA, 2009, 190 (03) : 158 - 159
  • [43] Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma
    Creaney, Jenette
    Yeoman, Deborah
    Demelker, Yvonne
    Segal, Amanda
    Musk, A. W.
    Skates, Steven J.
    Robinson, Bruce W. S.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) : 851 - 857
  • [44] ILK EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA CAN BE PREDICTIVE OF SURVIVAL
    Watzka, S. B.
    Burgstaller, R.
    Setinek, U.
    Dekan, G.
    Toetsch, M.
    Fleck, T.
    Weigel, G.
    Mueller, M. R.
    LUNG CANCER, 2009, 64 : S67 - S67
  • [45] Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma
    Bonotti, Alessandra
    Simonini, Silvia
    Pantani, Elena
    Giusti, Laura
    Donadio, Elena
    Mazzoni, Maria Rosa
    Chella, Antonio
    Marconi, Letizia
    Ambrosino, Nicolino
    Lucchi, Marco
    Mussi, Alfredo
    Cristaudo, Alfonso
    Foddis, Rudy
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2017, 32 (01): : E126 - E131
  • [46] Comparison of mesothelin and fibulin-3 in pleural fluid and serum as markers in malignant mesothelioma
    Creaney, Jenette
    Dick, Ian M.
    Robinson, Bruce W.
    CURRENT OPINION IN PULMONARY MEDICINE, 2015, 21 (04) : 352 - 356
  • [47] SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma
    Zhang, Yi
    He, Jianxing
    Zhang, Fang
    Li, Hui
    Yue, Dongsheng
    Wang, Changli
    Jablons, David M.
    He, Biao
    Lui, Natalie
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2013, 32
  • [48] SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma
    Yi Zhang
    Jianxing He
    Fang Zhang
    Hui Li
    Dongsheng Yue
    Changli Wang
    David M Jablons
    Biao He
    Natalie Lui
    Journal of Experimental & Clinical Cancer Research, 32
  • [49] Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma
    Burt, Bryan M.
    Lee, Hyun-Sung
    De Rosen, Veronica Lenge
    Hamaji, Masatsugu
    Groth, Shawn S.
    Wheeler, Thomas M.
    Sugarbaker, David J.
    ANNALS OF THORACIC SURGERY, 2017, 104 (05): : 1679 - 1687
  • [50] Soluble Mesothelin-Related Peptide and Osteopontin As Markers of Response in Malignant Mesothelioma
    Wheatley-Price, Paul
    Yang, Boming
    Patsios, Demetris
    Patel, Devalben
    Ma, Clement
    Xu, Wei
    Leighl, Natasha
    Feld, Ronald
    Cho, B. C. John
    O'Sullivan, Brenda
    Roberts, Heidi
    Tsao, Ming Sound
    Tammemagi, Martin
    Anraku, Masaki
    Chen, Zhuo
    de Perrot, Marc
    Liu, Geoffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3316 - 3322
12345